メタボリックシンドローム

□記事を途中から表示しています
[最初から表示]

^ Apridonidze T, Essah PA, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004; 90: 1929-1935.
^ Ruderman NB, Schneider SH, et al. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
^ Nakamura T, Tokunaga K, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Athyerosclerosis 1997; 107: 239-246.
^ Lamarche B, Tchernof A, et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998; 279: 1955-1961.
^ World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO Consultation. Geneva, World Health Org, 1999.
^ Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetes Med 1999; 16: 442-443.
^ Lemieux I, Pascot A, et al. Hypertriglyceridemic waist. A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000; 102: 179-184.
^ Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
^ Einhorn D, Reaven GM, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-252.
^ Ridker PM, Wilson PWF, et al. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825.
^ Grundy SM, Cleeman JI, et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
^ Kahn R, Buse J, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304.
^ a b Grundy SM. Does the metabolic syndrome exist? Diabetes Care 2006; 29: 1689-1692.
^ Kahn R. The metabolic syndrome (emperor) wears no clothes. Diabetes Care 2006; 29: 1693-1696.
^ a b c Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237-1247.
^ Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice. Am J Clin Nutr 2006; 83: 1248-1251.
^ Ferrannini E. Metabolic syndrome: a solution in search of a problem. J Clin Endocrinol Metab 2007; 92: 396-398.
^ Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404.
^ Kahn R. Metabolic syndrome. Is it a syndrome? Does it matter. Circulation 2007; 115: 1806-1811.
^ Beaser RS, Levy P. Metabolic syndrome. A work in progress, but a useful construct. Circulation 2007; 115: 1812-1818.
^ Sundstrom J, Vallhagen E, et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006; 29: 1673-1674.
^ Eckel RH, Kahn R, et al. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 2006; 113: 2943-2946.
^ Malik S, Wong ND, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
^ McNeil AM, Rosamond WD, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005; 28: 385-390.
^ Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 2005; 28: 1769-1778.
^ Wilson PWF, D’Agostino RB, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-3072.
^ The DECODE Study Group, Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006; 49: 2837-2846.
^ Gami AS, Witt BJ, et al. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007; 49: 403-414.
^ Ninomia T, Kubo M, et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population. The Hisayama Study. Stroke 2007; 38: 2063-2069.
^ Sone H, Tanaka S, et al. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions. Diabetes Care 2006; 29: 145-147.
^ Katzmarzyk PT, Janssen I, et al. The importance of waist circumference in the definition of metabolic syndrome. Prospective analyses of mortality in men. Diabetes Care 2006; 29: 404-409.
^ Chen H, Pan W. Probable blind spot in the International Diabetes Federation definition of metabolic syndrome. Obesity 2007; 15: 1096-1100.
^ Yoon YS, Lee ES, et al. The new definition of metabolic syndrome by the International Diabetes Federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised National Cholesterol Education Program: the Korea NHANES Study. Int J Obes 2007; 31: 528-534.
^ Tong PC, Kong AP, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program’s Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007; 30: 1206-1211.
^ Tanomsup S, Aekplakorn W, et al. A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand. Diabetes Care 2007; 30: 2138-2140.
^ Lorenzo C, Serrano-Rios M, et al. Is waist circumference an essential component of the metabolic syndrome? Diabetes Care 2007; 30: 2141-2142.
^ Klein S, Allison DB, et al. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 2007; 30: 1647-1652.

次ページ

記事の検索

おまかせリスト

Size:70 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef